Birdwatch Note
2024-04-06 15:43:10 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
小林製薬の工場で生産された紅麹を原料として使った他社製品での健康被害が無かったと報告されただけであり、小林製薬の工場で製造された紅麹使用サプリメントでは健康被害が報告されている以上、小林製薬がシロであると判断するのは時期尚早である。 https://news.ntv.co.jp/category/society/93bca517932e4a279383334965f58322 また、紅麹サプリメントと他社の紅麹使用食品とでは摂取量や摂取頻度が異なると考えられ単純比較できない。(一例として小林製薬が製造した紅麹を色素として使っていた発泡性日本酒の回収に関するプレスリリースを挙げる。嗜好品であり、サプリメントの様に毎日摂取するとは考えにくい。) https://www.takara.co.jp/news/__icsFiles/afieldfile/2024/03/23/TS23-045_7.pdf
Written by EC4C568A7A1FA3546D700C0C8B9BD74EB4E8D27CD93F84F2C3B46CD16C41C3E1
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1776522888297972017
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1776636775383122375
- noteId - 1776636775383122375
- participantId -
- noteAuthorParticipantId - EC4C568A7A1FA3546D700C0C8B9BD74EB4E8D27CD93F84F2C3B46CD16C41C3E1 Participant Details
- createdAtMillis - 1712418190224
- tweetId - 1776522888297972017
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 小林製薬の工場で生産された紅麹を原料として使った他社製品での健康被害が無かったと報告されただけであり、小林製薬の工場で製造された紅麹使用サプリメントでは健康被害が報告されている以上、小林製薬がシロであると判断するのは時期尚早である。 https://news.ntv.co.jp/category/society/93bca517932e4a279383334965f58322 また、紅麹サプリメントと他社の紅麹使用食品とでは摂取量や摂取頻度が異なると考えられ単純比較できない。(一例として小林製薬が製造した紅麹を色素として使っていた発泡性日本酒の回収に関するプレスリリースを挙げる。嗜好品であり、サプリメントの様に毎日摂取するとは考えにくい。) https://www.takara.co.jp/news/__icsFiles/afieldfile/2024/03/23/TS23-045_7.pdf
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-06 15:43:10 UTC (1712418190224) |
2024-04-07 02:42:43 UTC (1712457763632) |
CURRENTLY_RATED_HELPFUL | 2024-04-07 02:42:43 UTC (1712457763632) |
CURRENTLY_RATED_HELPFUL | 2024-04-07 02:42:43 UTC (1712457763632) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-06 20:18:40 -0500 | Rating Details | |
2024-04-06 20:04:39 -0500 | Rating Details | |
2024-04-06 19:58:19 -0500 | Rating Details | |
2024-04-06 19:45:08 -0500 | Rating Details | |
2024-04-06 19:45:05 -0500 | Rating Details | |
2024-04-06 19:38:21 -0500 | Rating Details | |
2024-04-06 19:34:36 -0500 | Rating Details | |
2024-04-06 19:24:12 -0500 | Rating Details | |
2024-04-06 19:05:44 -0500 | Rating Details | |
2024-04-06 18:46:27 -0500 | Rating Details | |
2024-04-06 18:45:18 -0500 | Rating Details | |
2024-04-06 18:44:49 -0500 | Rating Details | |
2024-04-06 18:44:47 -0500 | Rating Details | |
2024-04-06 18:00:21 -0500 | Rating Details | |
2024-04-06 17:45:55 -0500 | Rating Details | |
2024-04-06 16:51:57 -0500 | Rating Details | |
2024-04-06 16:09:56 -0500 | Rating Details | |
2024-04-06 16:09:15 -0500 | Rating Details | |
2024-04-06 12:25:40 -0500 | Rating Details | |
2024-04-06 12:02:18 -0500 | Rating Details | |
2024-04-06 11:24:05 -0500 | Rating Details | |
2024-04-07 16:53:33 -0500 | Rating Details | |
2024-04-07 10:14:59 -0500 | Rating Details | |
2024-04-07 07:04:09 -0500 | Rating Details | |
2024-04-07 04:52:27 -0500 | Rating Details | |
2024-04-07 04:50:35 -0500 | Rating Details | |
2024-04-07 04:47:08 -0500 | Rating Details | |
2024-04-07 04:36:12 -0500 | Rating Details | |
2024-04-07 04:28:34 -0500 | Rating Details | |
2024-04-07 03:03:49 -0500 | Rating Details | |
2024-04-06 23:49:52 -0500 | Rating Details | |
2024-04-06 23:34:39 -0500 | Rating Details | |
2024-04-06 23:33:43 -0500 | Rating Details | |
2024-04-06 22:20:37 -0500 | Rating Details | |
2024-04-06 22:09:49 -0500 | Rating Details | |
2024-04-06 21:46:13 -0500 | Rating Details | |
2024-04-06 21:31:56 -0500 | Rating Details | |
2024-04-06 21:25:38 -0500 | Rating Details | |
2024-04-06 21:09:22 -0500 | Rating Details | |
2024-04-06 21:05:24 -0500 | Rating Details | |
2024-04-06 21:02:23 -0500 | Rating Details | |
2024-04-07 20:33:07 -0500 | Rating Details | |
2024-04-11 23:10:32 -0500 | Rating Details | |
2024-04-16 01:28:08 -0500 | Rating Details | |
2024-04-10 11:13:02 -0500 | Rating Details | |
2024-04-07 12:22:38 -0500 | Rating Details | |
2024-04-07 09:15:22 -0500 | Rating Details | |
2024-04-07 08:40:14 -0500 | Rating Details | |
2024-04-07 06:08:35 -0500 | Rating Details | |
2024-04-07 04:47:09 -0500 | Rating Details | |
2024-04-07 04:44:22 -0500 | Rating Details | |
2024-04-07 04:42:10 -0500 | Rating Details | |
2024-04-07 04:41:20 -0500 | Rating Details | |
2024-04-07 04:38:21 -0500 | Rating Details | |
2024-04-07 04:37:26 -0500 | Rating Details | |
2024-04-07 04:36:26 -0500 | Rating Details | |
2024-04-07 00:42:16 -0500 | Rating Details | |
2024-04-07 00:03:41 -0500 | Rating Details | |
2024-04-06 23:43:54 -0500 | Rating Details | |
2024-04-06 23:25:22 -0500 | Rating Details | |
2024-04-06 21:51:17 -0500 | Rating Details | |
2024-04-06 21:50:28 -0500 | Rating Details | |
2024-04-06 21:46:23 -0500 | Rating Details | |
2024-04-06 21:01:26 -0500 | Rating Details | |
2024-04-06 20:48:49 -0500 | Rating Details | |
2024-04-06 20:30:40 -0500 | Rating Details | |
2024-04-06 19:58:08 -0500 | Rating Details | |
2024-04-06 19:57:32 -0500 | Rating Details | |
2024-04-06 19:56:37 -0500 | Rating Details | |
2024-04-06 19:49:41 -0500 | Rating Details | |
2024-04-06 19:22:27 -0500 | Rating Details | |
2024-04-06 19:11:09 -0500 | Rating Details | |
2024-04-06 17:28:09 -0500 | Rating Details | |
2024-04-06 16:53:34 -0500 | Rating Details | |
2024-04-06 16:16:53 -0500 | Rating Details | |
2024-04-06 16:02:55 -0500 | Rating Details | |
2024-04-06 14:13:54 -0500 | Rating Details | |
2024-04-06 14:07:33 -0500 | Rating Details | |
2024-04-06 13:16:09 -0500 | Rating Details | |
2024-04-06 13:05:47 -0500 | Rating Details | |
2024-04-06 12:40:40 -0500 | Rating Details | |
2024-04-06 12:13:41 -0500 | Rating Details | |
2024-04-06 11:45:17 -0500 | Rating Details | |
2024-04-06 11:34:27 -0500 | Rating Details | |
2024-04-06 11:29:23 -0500 | Rating Details | |
2024-04-06 10:59:46 -0500 | Rating Details | |
2024-04-07 00:57:30 -0500 | Rating Details | |
2024-04-08 03:01:35 -0500 | Rating Details | |
2024-04-07 08:52:32 -0500 | Rating Details | |
2024-08-04 01:40:33 -0500 | Rating Details | |
2024-09-21 05:37:34 -0500 | Rating Details | |
2024-10-10 12:25:34 -0500 | Rating Details |